Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
View/ Open
Author
Bermudez, Jorge
't Hoen, Ellen
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1371/journal.pmed.1001218Metadata
Show full item recordCitation
Moon, Suerie, Jorge Bermudez, and Ellen 't Hoen. 2012. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Medicine 9(5): e1001218.Abstract
As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue for a global health R&D treaty to improve innovation in new medicines and strengthening affordability, sustainable financing, efficiency in innovation, and equitable health-centered governance.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352855/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:10484011
Collections
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)